|
|
231 Bonetti Drive San Luis Obispo, CA 93401 USA phone:805.546.0610 fax:805.546.0571
|
|
| Symbol |
private |
| Founded |
1996 |
| Employees |
25 |
|
|
| www.fziomed.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Development and commercialization of synthetic, resorbable surgical biomaterials. |
 |
| Management |
| John Krelle, CEO |
| |
|
|
| |
|
| Keywords |
| polyethylene, carboxymethylcellulose, orthopedics, gynecology, aesthetic |
|
|
|
| Description |
|
FzioMed is a privately held medical device company engaged in the development and commercialization of synthetic, resorbable surgical biomaterials. |
 |
| Products / Services |
Products include Oxiplex Gel, an adhesion barrier for spine surgery approved for sale in forty-seven countries outside the United States and with more than 250,000 patients treated worldwide. Intercoat Gel, an adhesion barrier for abdominal and pelvic surgery, is distributed in the European Union by Ethicon Women's Health and Urology.
|
 |
| Technology / Differentiation |
| FzioMed's science is based on the combination of well-studied, biocompatible medical polymers, carboxymethylcellulose (CMC) and polyethylene oxide (PEO). These polymers are used separately in pharmaceuticals, medical devices, and nutritional products. Combined together, they make an ideal and versatile technology platform with key advantages over other biomaterial technologies. |
 |
 |
|
|
|
|
|
|